title: Reply to Comparison of cervical cancer screening results among 256,648 women in multiple clinical practices.
authors.affiliation: Quest Diagnostics, Madison, New Jersey.
authors.forename: Douglas S
authors.initials: DS
authors.lastname: Rabin
authors.affiliation: Quest Diagnostics, Madison, New Jersey.
authors.forename: Amy J
authors.initials: AJ
authors.lastname: Blatt
authors.affiliation: Quest Diagnostics, Madison, New Jersey.
authors.forename: Ronald
authors.initials: R
authors.lastname: Kennedy
authors.affiliation: Clinical Trials, Quest Diagnostics, Madison, New Jersey.
authors.forename: Ronald D
authors.initials: RD
authors.lastname: Luff
authors.affiliation: Department of Cytopathology, Magee-Women's Hospital of the University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
authors.forename: R Marshall
authors.initials: RM
authors.lastname: Austin
mesh_terms: D055088:Early Detection of Cancer / Q000379:methods*; D005260:Female; D006801:Humans; D027383:Papillomaviridae / Q000302:isolation & purification*; D030361:Papillomavirus Infections / Q000473:pathology*; D002583:Uterine Cervical Neoplasms / Q000473:pathology* / Q000821:virology*